Glutamate enrichment as new diagnostic opportunity in breast cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutamate enrichment as new diagnostic opportunity in breast cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 7, Pages 1619-1628
Publisher
Wiley
Online
2014-08-23
DOI
10.1002/ijc.29152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- cancerclass: AnRPackage for Development and Validation of Diagnostic Tests from High-Dimensional Molecular Data
- (2015) Jan Budczies et al. Journal of Statistical Software
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
- (2014) L. Yang et al. Molecular Systems Biology
- Anticancer Activities of PPARγ in Breast Cancer Are Context-Dependent
- (2013) Jin-Tang Dong AMERICAN JOURNAL OF PATHOLOGY
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- Therapeutic strategies impacting cancer cell glutamine metabolism
- (2013) Michael J Lukey et al. Future Medicinal Chemistry
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
- (2013) Atsushi Terunuma et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism
- (2013) Jan Budczies et al. Journal of Proteomics
- Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
- (2013) J. Fan et al. Molecular Systems Biology
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Data, information, knowledge and principle: back to metabolism in KEGG
- (2013) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate
- (2012) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies
- (2012) Ann-Kristin Petersen et al. BMC BIOINFORMATICS
- Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study
- (2012) Jan Budczies et al. BMC GENOMICS
- How cancer metabolism is tuned for proliferation and vulnerable to disruption
- (2012) Almut Schulze et al. NATURE
- Rho GTPases and their roles in cancer metabolism
- (2012) Kristin F. Wilson et al. TRENDS IN MOLECULAR MEDICINE
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Detection of 2-Hydroxyglutarate in Formalin-Fixed Paraffin-Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry
- (2011) Felix Sahm et al. BRAIN PATHOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer Metabolism: Is Glutamine Sweeter than Glucose?
- (2010) Weiqin Lu et al. CANCER CELL
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Metabolic transformation in cancer
- (2009) D. A. Tennant et al. CARCINOGENESIS
- Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover
- (2008) Carsten Denkert et al. Molecular Cancer
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started